Stay updated with breaking news from Multiple Ascending Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
STOCKHOLM, SE / ACCESSWIRE / April 21, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes to those statements included... | March 31, 2022
Artl_10kt.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION ... | March 21, 2022
STOCKHOLM, SWEDEN / ACCESSWIRE / March 15, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
Pipe-307 demonstrated linear pharmacokinetic (PK) data consistent with pre-clinical modelling and was generally well tolerated.